John R. Arrand

3.4k total citations · 1 hit paper
56 papers, 2.7k citations indexed

About

John R. Arrand is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, John R. Arrand has authored 56 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 16 papers in Molecular Biology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in John R. Arrand's work include Viral-associated cancers and disorders (31 papers), Lymphoma Diagnosis and Treatment (13 papers) and Parvovirus B19 Infection Studies (9 papers). John R. Arrand is often cited by papers focused on Viral-associated cancers and disorders (31 papers), Lymphoma Diagnosis and Treatment (13 papers) and Parvovirus B19 Infection Studies (9 papers). John R. Arrand collaborates with scholars based in United Kingdom, United States and China. John R. Arrand's co-authors include Beverly E. Griffin, M. Mackett, Eiichi Soeda, Richard J. Roberts, Lawrence S. Young, Shahram Salek‐Ardakani, Nina Smolar, William O. Dawson, James P. Stewart and John D. O’Neil and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

John R. Arrand

55 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Coding potential and regulatory signals of the polyoma virus genome

1980 339 citations John R. Arrand et al. profile →

Peers

John R. Arrand

ONCOL

EPIDE

IMMUN

PFM

Päivi M. Ojala Finland

Marvin S. Reitz United States

John L. Yates United States

Alfredo Corallini Italy

Joëlle Wiels France

Aldo Venuti Italy

R Risser United States

Tatsuya Tsurumi Japan

Cary A. Moody United States

Susan M. Astrin United States

Päivi M. Ojala Finland

John R. Arrand

1.4k ×1.0

ONCOL

1.4k ×1.4

756 ×1.3

EPIDE

315 ×0.6

IMMUN

292 ×0.7

PFM

Citations per year, relative to John R. Arrand John R. Arrand (= 1×) peers Päivi M. Ojala

Countries citing papers authored by John R. Arrand

Since Specialization

Citations

This map shows the geographic impact of John R. Arrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Arrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Arrand more than expected).

Fields of papers citing papers by John R. Arrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Arrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Arrand. The network helps show where John R. Arrand may publish in the future.

Co-authorship network of co-authors of John R. Arrand

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Arrand. A scholar is included among the top collaborators of John R. Arrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Arrand. John R. Arrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Palser, Anne, Nicholas Grayson, Robert E. White, et al.. (2015). Genome Diversity of Epstein-Barr Virus from Multiple Tumor Types and Normal Infection. Journal of Virology. 89(10). 5222–5237. 187 indexed citations

Hu, Chunfang, Wenbin Wei, Xiaoyi Chen, et al.. (2012). A Global View of the Oncogenic Landscape in Nasopharyngeal Carcinoma: An Integrated Analysis at the Genetic and Expression Levels. PLoS ONE. 7(7). e41055–e41055. 51 indexed citations

Zhao, Zheng-yun, et al.. (2011). Detection of single nucleotide polymorphisms within a sequence of a gene associated with prostate cancer using a fluorophore-tagged DNA probe. Bioorganic & Medicinal Chemistry Letters. 22(1). 129–132. 11 indexed citations

Arrand, John R.. (2010). Prospects for a vaccine against Epstein-Barr virus. 5(4). 188–193.

Valentine, Robert, William O. Dawson, Chunfang Hu, et al.. (2010). Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylation. Molecular Cancer. 9(1). 1–1. 296 indexed citations

Bose, Shikha, Lee Fah Yap, Amyza Saleh, et al.. (2008). The ATM tumour suppressor gene is down‐regulated in EBV‐associated nasopharyngeal carcinoma. The Journal of Pathology. 217(3). 345–352. 81 indexed citations

Wei, Wenbin, Richard J. Armitage, John R. Arrand, et al.. (2007). CD154 Tone Sets the Signaling Pathways and Transcriptome Generated in Model CD40-Pluricompetent L3055 Burkitt’s Lymphoma Cells. The Journal of Immunology. 179(5). 2705–2712. 14 indexed citations

Felton-Edkins, Zoë A., Alexander Kondrashov, Jennifer A. Fairley, et al.. (2006). Epstein-Barr Virus Induces Cellular Transcription Factors to Allow Active Expression of EBER Genes by RNA Polymerase III. Journal of Biological Chemistry. 281(45). 33871–33880. 39 indexed citations

Salek‐Ardakani, Shahram, et al.. (2004). Epstein-Barr Virus Promotes Human Monocyte Survival and Maturation through a Paracrine Induction of IFN-α. The Journal of Immunology. 173(1). 321–331. 16 indexed citations

10.

Salek‐Ardakani, Shahram, John R. Arrand, & M. Mackett. (2002). Epstein–Barr Virus Encoded Interleukin-10 Inhibits HLA-Class I, ICAM-1, and B7 Expression on Human Monocytes: Implications for Immune Evasion by EBV. Virology. 304(2). 342–351. 75 indexed citations

11.

Salek‐Ardakani, Shahram, et al.. (2002). HIGH LEVEL EXPRESSION AND PURIFICATION OF THE EPSTEIN-BARR VIRUS ENCODED CYTOKINE VIRAL INTERLEUKIN 10: EFFICIENT REMOVAL OF ENDOTOXIN. Cytokine. 17(1). 1–13. 29 indexed citations

12.

Jenson, Hal B., Yasmin Ench, Shou‐Jiang Gao, et al.. (2000). Epidemiology of Herpesvirus Papio Infection in a Large Captive Baboon Colony: Similarities to Epstein‐Barr Virus Infection in Humans. The Journal of Infectious Diseases. 181(4). 1462–1466. 19 indexed citations

13.

Mackett, M., Charles D. Cox, Stuart D Pepper, et al.. (1996). Immunisation of common marmosets with vaccinia virus expressing Epstein-Barr virus (EBV) gp340 and challenge with EBV. Journal of Medical Virology. 50(3). 263–271. 22 indexed citations

14.

Wrightham, M, James P. Stewart, Stuart D Pepper, et al.. (1995). Antigenic and Sequence Variation in the C-Terminal Unique Domain of the Epstein-Barr Virus Nuclear Antigen EBNA-1. Virology. 208(2). 521–530. 59 indexed citations

15.

Bartholomew, Jennifer S., Simon Stacey, Brian Coles, et al.. (1994). Identification of a naturally processed HLA A0201‐restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein. European Journal of Immunology. 24(12). 3175–3179. 33 indexed citations

16.

Stacey, Simon, A K Ghosh, Jennifer S. Bartholomew, et al.. (1993). Expression of human papillomavirus type 16 E7 protein by recombinant baculovirus and use for the detection of E7 antibodies in sera from cervical carcinoma patients. Journal of Medical Virology. 40(1). 14–21. 13 indexed citations

17.

Stewart, James P. & John R. Arrand. (1993). Expression of the Epstein-Barr virus latent membrane protein in nasopharyngeal carcinoma biopsy specimens. Human Pathology. 24(3). 239–242. 29 indexed citations

18.

Ghosh, A K, Nigel Smith, Simon Stacey, et al.. (1993). Serological responses to HPV 16 in cervical dysplasia and neoplasia: Correlation of antibodies to E6 with cervical cancer. International Journal of Cancer. 53(4). 591–596. 34 indexed citations

19.

Lees, Janice F., et al.. (1992). Detection of EBV DNA in post‐nasal space biopsy tissue from asymptomatic EBV‐seropositive individuals. Journal of Medical Virology. 37(1). 30–38. 17 indexed citations

20.

Clarke, Paul A., Nigel A. Sharp, John R. Arrand, & Michael J. Clemens. (1990). Epstein-Barr virus gene expression in interferon-treated cells. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1050(1-3). 167–173. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact